The psychedelic DOI reduces anxiety by targeting specific neurons in the ventral hippocampus, offering a…
Browsing: Psychedelics
Psychedelics are a class of psychoactive substances that produce profound changes in perception, mood, and cognitive processes. These substances, which include LSD, psilocybin (found in magic mushrooms), and DMT, have been used for thousands of years, often in religious or spiritual contexts. Modern interest in psychedelics surged in the mid-20th century, leading to extensive research into their potential therapeutic effects. However, the legal status of these substances became restricted under international conventions in the 1970s, greatly limiting their scientific study. In recent years, there has been a resurgence of interest in the potential of psychedelics to treat various mental health disorders such as depression, PTSD, and anxiety, with numerous clinical trials showing promising results. This has led to a reevaluation of their legal status and increased funding for psychedelic research in several countries.
Psilocybin is as good as SSRI for depression, but doesn’t lower sex drive and gives…
New analysis reveals that over half of patients treated for depression may be eligible for…
Cannabis and hallucinogen use among adults remained at historic highs in 2023. Vaping among younger…
Psychedelic substances like psilocybin, ketamine, and MDMA, once dismissed as mere “party drugs,” are being…
One study will investigate the alterations in brain activity at the cellular level caused by…
Mushroom gummies marketed for brain health have been found to contain illegal psilocybin and other…
New research highlights a significant increase in interest in microdosing, with a 1250% rise in…
Study shows psilocybin induces dynamic brain connectivity, linked to profound, ego-altering experiences, potentially beneficial in…
Findings are encouraging but further evidence is needed before any clinical recommendations can be made,…
New study sheds light on the structure and evolution of an enzyme in psychoactive fungi.…
Discovery opens door to developing non-toxic fast and sustained-effect antidepressants. ‘Ketamine alongside conventional antidepressants could…
Clinical trial results support further study of this psychedelic substance, administered with psychological support from…
Severe depression and treatment-resistant depression (TRD) are prevalent conditions. About one-third of patients show no…
Increases the number of patients likely to respond to treatment for major depression. A major…
Recent research indicates that ketamine, traditionally an anesthetic, can quickly reduce PTSD and depression symptoms.…
Journal of Psychiatric Practice presents review and update on psychedelics for mental disorders. A growing…
Although the brain’s capacity for change is usually slow, it can be rapidly enhanced through…